Updated Jul 16, 2026
Katkin Keith has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $128K.
Keith Katkin is listed as an insider of Eledon Pharmaceuticals, Inc. (ELDN) in the SEC filing with CIK 0001314596. The most recent filing dated 2026-01-16 shows zero purchases and zero sales, with only a single Form 4 filing reported, and the filing context does not specify a formal current role or title.
| Role | Director |
|---|---|
| Notability | 28/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-04 | EBS | Emergent BioSolutions Inc. | S — Open-market sale | 15.5K | $8.28 | $128K |
| 2026-05-04 | EBS | Emergent BioSolutions Inc. | A — Grant or award | 25.3K | $0.00 | |
| 2026-02-06 | SNDX | Syndax Pharmaceuticals Inc | A — Grant or award | 24.0K | $0.00 | |
| 2026-01-16 | ELDN | Eledon Pharmaceuticals, Inc. | M — Option exercise | 8.6K | $0.00 |
Keith Katkin is listed as an insider of Eledon Pharmaceuticals, Inc. (ELDN) in the SEC filing with CIK 0001314596. The most recent filing dated 2026-01-16 shows zero purchases and zero sales, with only a single Form 4 filing reported, and the filing context does not specify a formal current role or title.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($128K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Katkin Keith profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.